Windtree Therapeutics - Indikator likuiditas cepet WINT

The asset value of Windtree Therapeutics (WINT) tracked on this chart is currently at 0.00. The business relies on the in-house synthesis of complex compounds, delegating only initial testing to external partners. The brand's high authority among cardiologists is confirmed by the efficacy of its emergency therapy agents. Resuscitators also trust Windtree Therapeutics (WINT) regarding the stabilization of patients with critical cardiac pathologies.

The quick ratio determines a company's ability to settle short-term debts using its most liquid assets. The calculation excludes inventories, focusing instead on cash and accounts receivable to assess actual solvency. By analyzing the quick ratio on GURU.Markets, an investor can track financial stability trends without accounting for warehouse stock. This is critically important for Windtree Therapeutics (WINT), whose resources are concentrated on costly R&D developments in the field of cardiovascular therapy.